STOCK TITAN

So-Young International Inc. American Depository Shares - $SY STOCK NEWS

Welcome to our dedicated page for So-Young International American Depository Shares news (Ticker: $SY), a resource for investors and traders seeking the latest updates and insights on So-Young International American Depository Shares stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect So-Young International American Depository Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of So-Young International American Depository Shares's position in the market.

Rhea-AI Summary
So-Young International Inc. (Nasdaq: SY) has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023. The report is available on the company's investor relations website. Shareholders and ADS holders can request a hard copy of the report for free.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
none
-
Rhea-AI Summary
So-Young International Inc. Announces Strong Financial Results for Q4 2023 and FY 2023, Declares Share Repurchase Program and Special Cash Dividend
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
-
Rhea-AI Summary
So-Young International Inc. (SY) will report its financial results for Q4 and full year 2023 on March 20, 2024. The earnings conference call will be held at 7:30 AM U.S. Eastern Time. Details for dial-in and webcast are provided for investors and analysts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.76%
Tags
conferences earnings
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) announced the repurchase of approximately 13.3 million ADSs, representing 10.3 million Class A ordinary shares, for US$54.5 million. The company plans to cancel all repurchased shares, reflecting a strategic move in its capital structure.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
buyback
-
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) announced the approval of 2,923,077 restricted share units for Mr. Xing Jin, the chairman and CEO, to recognize his contribution and incentivize him to lead the company to greater business results. Mr. Jin has agreed not to sell more than one-third of the total Class A ordinary shares to be issued upon the vesting of the Restricted Share Units in each year ending December 31, 2024, 2025 and 2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.42%
Tags
none
-
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) has announced a strategic partnership with Healtech to develop regenerative medical aesthetic products and expand its supply chain business. The partnership aims to leverage So-Young's consumer reach and Healtech's R&D capabilities to bring new products to the market quickly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.22%
Tags
partnership
Rhea-AI Summary
So-Young International Inc. (Nasdaq: SY) announced unaudited financial results for Q3 2023, showing total revenues of RMB385.3 million, a 19.2% increase from the same period in 2022. Net income attributable to So-Young was RMB18.3 million, compared to RMB2.3 million in Q3 2022. The company's average mobile MAUs were 3.1 million, and the number of medical service providers subscribing to information services on So-Young's platform decreased to 1,397 from 1,704 in Q3 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.4%
Tags
-
Rhea-AI Summary
So-Young International Inc. (Nasdaq: SY) announces that its subsidiary, Wuhan Miracle, has submitted application documents for a potential IPO and listing on the Beijing Stock Exchange. Wuhan Miracle plans to issue up to 20,000,000 shares, accounting for approximately 25% of its total share capital after the IPO. So-Young currently owns approximately 87.60% of Wuhan Miracle's shares.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
So-Young International Inc. (NASDAQ: SY) announces the release of its financial results for the third quarter of 2023 on November 20, 2023, along with an earnings conference call. The company is the largest social community in China for the medical aesthetics industry. Dial-in and webcast details are provided for the conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.9%
Tags
conferences earnings
News
Rhea-AI Summary
So-Young International announces resignations and new appointments of directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.15%
Tags
none
So-Young International Inc. American Depository Shares

Nasdaq:SY

SY Rankings

SY Stock Data

140.77M
34.85M
16.79%
27.59%
0.05%
Data Processing, Hosting, and Related Services
Information
Link
United States of America
Beijing

About SY

so-young international inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. its platform enables users to discover content and share their own experience on medical aesthetics procedures, and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the people's republic of china and internationally. the company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name beauty diaries. it also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; software as a service; and guiding and consulting services through training programs for medical service providers. as of december 31, 2019, the company had approximately 6,100 medical aesthetic service prov